title: Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates.
abstract: We have purified from rat peritoneal exudates a 37-kDa protein that inhibits phospholipase A2 activity. It is the predominant phospholipase inhibitor protein in these preparations and also is detected in a wide variety of cell lines. Levels of expression range from 0 to 0.5% of total protein. In the peritoneal preparations, the inhibitor is partially proteolyzed into a series of lower mass forms, including species at 30, 24, and 15 kDa. These fragments all are immunoreactive with an antibody raised against the 37-kDa protein. The rat protein also is immunoreactive with an antibody developed against a 6-kDa phospholipase inhibitor protein from snake venom. The primary structure of more than half of the rat inhibitor has been deduced by protein microsequence analysis. These sequences are closely related to sequences from its human analogue, which we recently cloned and expressed (Wallner, B. P., Mattaliano, R. J., Hession, C., Cate, R. L., Tizard, R., Sinclair, L. K., Foeller, C., Chow, E. P., Browning, J. L., Ramachandran, K. L., and Pepinsky, R. B. (1986) Nature, in press), and thus we infer that the inhibitor is highly conserved evolutionarily. Properties of the molecule suggest that it is a member of a family of steroid-induced anti-inflammatory proteins collectively referred to as lipocortin.
authors.forename: R B
authors.initials: RB
authors.lastname: Pepinsky
authors.forename: L K
authors.initials: LK
authors.lastname: Sinclair
authors.forename: J L
authors.initials: JL
authors.lastname: Browning
authors.forename: R J
authors.initials: RJ
authors.lastname: Mattaliano
authors.forename: J E
authors.initials: JE
authors.lastname: Smart
authors.forename: E P
authors.initials: EP
authors.lastname: Chow
authors.forename: T
authors.initials: T
authors.lastname: Falbel
authors.forename: A
authors.initials: A
authors.lastname: Ribolini
authors.forename: J L
authors.initials: JL
authors.lastname: Garwin
authors.forename: B P
authors.initials: BP
authors.lastname: Wallner
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D002850:Chromatography, Gel; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000302:isolation & purification*; D005122:Exudates and Transudates / Q000032:analysis*; D000882:Haplorhini; D006801:Humans; D008297:Male; D051379:Mice; D008970:Molecular Weight; D010446:Peptide Fragments / Q000032:analysis; D010740:Phospholipases / Q000037:antagonists & inhibitors*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution; D014357:Trypsin / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D010446:Peptide Fragments; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2; D014357:Trypsin